Purpose: Arterial thromboembolism in patients with. an unknown source of em
bolization is still associated with significant morbidity and mortality. Th
e advent of transesophageal echocardiography (TEE) and magnetic resonance i
maging (MRI) and the more frequent use of computed tomography (CT) have led
to the identification of mural aortic thrombi (MAT) as a source of distal
embolization in a much higher proportion of patients than previously apprec
iated. The incidence, diagnosis, and treatment of patients with MAT is repo
rted.
Methods: Ln a prospective study, from January 1996 to December 1998, 89 pat
ients with acute embolic events underwent an extensive diagnostic workup, c
onsisting of TEE, CT, or MRI, to detect the source of embolization. Patient
s in whom the heart (n = 51), occlusive aortoiliac disease (n = 16), or aor
tic aneurysms (n = 12) was identified as the source of embolization were ex
cluded.
Results Five female and three male patients, with a median age of 63 years
(range, 35 to 76 years), with bilateral or repetitive embolic events result
ing from MAT were identified, representing 9% of all patients with arterial
thrombembolism, All patients had several risk factors for atherosclerosis,
but only one young patient had a single risk factor that promoted thrombos
is. Successful percutaneous catheter aspiration embolectomy was performed i
n six patients. The remaining two patients underwent surgical thromboembole
ctomy. A below-knee amputation had to be performed in two patients, thus re
presenting a morbidity of the primary treatment of 25%. MAT of equal value
were detected in the ascending (n = 1) and thoracic aorta (n = 3) by means
of TEE, CT, or MRI. MAT in the abdominal aorta (n = 4) were identified by m
eans of CT and MRI. Surgical removal of MAT was performed in seven patients
by means of graft replacement of the ascending aorta (n = 1), open thrombe
ctomy of the descending aorta (n = 2), and thrombendarterectomy of the abdo
minal aorta (n = 4), without intraoperative or postoperative complications,
No recurrence of MAT occurred during a median follow-up period of 13 month
s (range, 4 to 24 months).
Conclusion: MAT represent an important source of arterial thrombembolism. A
diagnostic workup, of the aorta, preferably by means of CT or MRI, should
be performed in all patients in whom other sources of embolization have bee
n ruled out. The ideal therapeutic approach to these patients still a-waits
prospective evaluation, However, based on our experience, MAT can be succe
ssfully treated with a definitive surgical procedure in selected patients,
with low mortality and morbidity.